Change of chief executive functions
Filed with HKEX · Stock code 314 · · 3 pages · English
Summary by 6ix AI
Sipai Health Technology Co., Ltd. has announced a change in its chief executive functions to enhance corporate governance and align with listing rules. Mr. Ma Xuguang will step down as CEO but will remain as President and Chairman, while Mr. Li Ji will take over as CEO. Both executives confirmed no disagreements with the Board regarding these changes, which will take effect in the future. The Board expressed appreciation for both Mr. Ma and Mr. Li in their new roles, ensuring continued leadership of the Group.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sipai Health Technology Co., Ltd. on 6ix
Earlier from Sipai Health Technology
- Discloseable transaction redemptions of wealth management product
- Voluntary announcement - adoption of the 2026 share award scheme
- Further announcement on major transaction disposal of 100% equity interest in the target company and delay in despatch of circular
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement acquisition of a 90% indirect equity interest in a licensed insurance broker company
Follow Sipai Health Technology into a list and get an email when it puts out news.
Follow Sipai Health Technology